跳至主要内容
临床试验/NCT04365803
NCT04365803进行中(未招募)不适用

Comparison Between Histological VABB and Histological Post-surgery in Patient With Complete Pathological Response After Neoadjuvant Systemic Treatment: Pilot Study

European Institute of Oncology1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2018年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
22
试验地点
1
主要终点
Evaluation of the accuracy of histological examination of the VABB performed pre-surgery

研究概览

简要总结

Pilot study on patients with invasive ductal breast cancer triple negative or receptor tyrosine-protein kinase erbB-2 (HER2) overexpressed, any axillary lymphnodes status (any cN), candidates to neoadjuvant chemotherapy.

The principal endpoint of the study will be the accuracy of the result of the histological examination of the Vacuum- Assisted Breast Biopsy (VABB) performed pre-surgery in comparison to the result of the histological examination of the definitive surgical intervention in patients with radiological complete response at Magnetic resonance imaging (MRI) done after the end of neoadjuvant chemotherapy.

详细描述

The study articulates in five phases:

Phase one: acquisition of the informed consent followed by positioning a clip into the cancer bed (by radiologist) if not already present; Phase two: after radiological confirmation of pathological Complete Response (pCR) done performing breast ultrasound, MRI and 18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose positron emission tomography (18-FDG-PET) after neoadjuvant chemotherapy the patient becomes candidate to VABB pre surgery.

Phase three: the patient has VABB within 15 day from the term of neoadjuvant chemotherapy Phase four: definitive surgical intervention within 30 days from the end of the neoadjuvant chemotherapy Phase five: verification of correspondence between histology of VABB and definitive histology.

The study hypothesis is that VABB could be used in the patients with pCR to the imaging post-neoadjuvant chemotherapy to confirm sensibility and specificity of 18 FDG TC PET and breast MRI to show the absence of breast cancer.

The use of VABB with negative histology result could bring to a therapeutic gold standard without over surgical treatment

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • age ≥ 18 aa;
  • histological diagnosis done at European Institute of Oncology (if not, to does revision of pathological material);
  • invasive ductal breast cancer triple negative or HER2 overexpressed, any cN;
  • neoadjuvant standard systemic treatment after surgery +/- trastuzumab;
  • propose of conservative or demolitive surgery;
  • cancer bed identified pre neoadjuvant chemotherapy by clip

排除标准

  • multicentric or bilateral breast cancer
  • mammography microcalcifications
  • in situ breast carcinoma
  • positive anamnesis for previous breast cancer
  • positive anamnesis for medical or psychological conditions that prevent membership study

结局指标

主要结局

Evaluation of the accuracy of histological examination of the VABB performed pre-surgery

时间窗: 45 days

Identification of percentage of cases with correspondence between histology of VABB presurgery and histology of definitive surgery in patients with complete radiological response after neoadjuvant chemotherapy

次要结局

未报告次要终点

研究者

发起方
European Institute of Oncology
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验